Equities analysts expect Exponent, Inc. (NASDAQ:EXPO) to report earnings of $0.35 per share for the current fiscal quarter, Zacks Investment Research reports. Two analysts have provided estimates for Exponent’s earnings, with the highest EPS estimate coming in at $0.35 and the lowest estimate coming in at $0.34. Exponent reported earnings of $0.34 per share during the same quarter last year, which would suggest a positive year-over-year growth rate of 2.9%. The firm is scheduled to issue its next earnings results on Thursday, July 18th.
According to Zacks, analysts expect that Exponent will report full year earnings of $1.37 per share for the current year, with EPS estimates ranging from $1.36 to $1.39. For the next fiscal year, analysts anticipate that the business will post earnings of $1.50 per share, with EPS estimates ranging from $1.48 to $1.51. Zacks Investment Research’s EPS calculations are an average based on a survey of analysts that cover Exponent.
Exponent (NASDAQ:EXPO) last posted its quarterly earnings results on Thursday, April 18th. The business services provider reported $0.42 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.35 by $0.07. Exponent had a return on equity of 23.24% and a net margin of 19.53%. The firm had revenue of $93.40 million during the quarter, compared to the consensus estimate of $93.52 million. During the same period last year, the company earned $0.75 earnings per share. The business’s revenue was up 3.0% compared to the same quarter last year.
Shares of NASDAQ EXPO opened at $56.45 on Friday. Exponent has a 12 month low of $41.90 and a 12 month high of $58.42. The company has a market cap of $2.93 billion, a PE ratio of 45.16 and a beta of 0.47.
The firm also recently announced a quarterly dividend, which will be paid on Friday, June 21st. Stockholders of record on Friday, June 7th will be paid a dividend of $0.16 per share. The ex-dividend date of this dividend is Thursday, June 6th. This represents a $0.64 annualized dividend and a dividend yield of 1.13%. Exponent’s dividend payout ratio is currently 51.20%.
In related news, insider Harri Kytomaa sold 2,366 shares of Exponent stock in a transaction that occurred on Friday, February 22nd. The stock was sold at an average price of $56.27, for a total transaction of $133,134.82. Following the completion of the sale, the insider now directly owns 3,816 shares of the company’s stock, valued at approximately $214,726.32. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders own 2.30% of the company’s stock.
A number of large investors have recently added to or reduced their stakes in the stock. Isthmus Partners LLC lifted its holdings in Exponent by 208.5% during the 1st quarter. Isthmus Partners LLC now owns 96,172 shares of the business services provider’s stock worth $7,771,000 after purchasing an additional 64,995 shares during the last quarter. Strs Ohio lifted its holdings in Exponent by 50.0% during the 1st quarter. Strs Ohio now owns 14,100 shares of the business services provider’s stock worth $813,000 after purchasing an additional 4,700 shares during the last quarter. Conestoga Capital Advisors LLC lifted its holdings in Exponent by 0.4% during the 1st quarter. Conestoga Capital Advisors LLC now owns 2,319,167 shares of the business services provider’s stock worth $133,862,000 after purchasing an additional 8,446 shares during the last quarter. We Are One Seven LLC lifted its holdings in Exponent by 80.5% during the 1st quarter. We Are One Seven LLC now owns 4,773 shares of the business services provider’s stock worth $275,000 after purchasing an additional 2,128 shares during the last quarter. Finally, Clarus Wealth Advisors acquired a new stake in Exponent during the 1st quarter worth approximately $221,000. 90.18% of the stock is owned by institutional investors and hedge funds.
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation.
Recommended Story: What are retained earnings?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.